Literature DB >> 21851399

How should clinicians interpret cardiac troponin values in patients with ESRD?

Nishank Jain1, S Susan Hedayati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21851399      PMCID： PMC3216403          DOI： 10.1111/j.1525-139X.2011.00912.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN： 0894-0959            Impact factor:   3.455


× No keyword cloud information.
  16 in total

Review 1.  Biochemical factors influencing measurement of cardiac troponin I in serum.

Authors:  A Katrukha; A Bereznikova; V Filatov; T Esakova
Journal:  Clin Chem Lab Med       Date:  1999 Nov-Dec       Impact factor: 3.694

2.  Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease.

Authors:  Fred S Apple; MaryAnn M Murakami; Lesly A Pearce; Charles A Herzog
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

3.  Cardiac troponin T and I in end-stage renal failure.

Authors:  D Wayand; H Baum; G Schätzle; J Schärf; D Neumeier
Journal:  Clin Chem       Date:  2000-09       Impact factor: 8.327

4.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

Authors:  J S Alpert; K Thygesen; E Antman; J P Bassand
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

5.  Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients.

Authors:  Francesca Mallamaci; Carmine Zoccali; Saverio Parlongo; Giovanni Tripepi; Francesco A Benedetto; Sebastiano Cutrupi; Grazia Bonanno; Pasquale Fatuzzo; Francesco Rapisarda; Giuseppe Seminara; Benedetta Stancanelli; Ignazio Bellanuova; Alessando Cataliotti; Lorenzo S Malatino
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

Review 6.  Comparison of cardiac troponin T and troponin I assays--implications of analytical and biochemical differences on clinical performance.

Authors:  Evangelos Giannitsis; Hugo A Katus
Journal:  Clin Lab       Date:  2004       Impact factor: 1.138

7.  Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.

Authors:  Christopher deFilippi; Steven Wasserman; Salvatore Rosanio; Eric Tiblier; Heidi Sperger; Monica Tocchi; Robert Christenson; Barry Uretsky; Mathew Smiley; Judith Gold; Henry Muniz; John Badalamenti; Charles Herzog; William Henrich
Journal:  JAMA       Date:  2003-07-16       Impact factor: 56.272

8.  Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction.

Authors:  Ronnier J Aviles; Arman T Askari; Bertil Lindahl; Lars Wallentin; Gang Jia; E Magnus Ohman; Kenneth W Mahaffey; L Kristin Newby; Robert M Califf; Maarten L Simoons; Eric J Topol; Peter Berger; Michael S Lauer
Journal:  N Engl J Med       Date:  2002-06-27       Impact factor: 91.245

9.  Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients.

Authors:  Jart H C Diris; Christian M Hackeng; Jeroen P Kooman; Yigal M Pinto; Wim T Hermens; Marja P van Dieijen-Visser
Journal:  Circulation       Date:  2003-12-22       Impact factor: 29.690

10.  Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study.

Authors:  Marie C Iliou; Christine Fumeron; Marie O Benoit; Philippe Tuppin; Victorio Menoyo Calonge; Nicole Moatti; Claude Buisson; Christian Jacquot
Journal:  Am J Kidney Dis       Date:  2003-09       Impact factor: 8.860
View more
  7 in total

Review 1.  Coronary artery disease in dialysis patients: evidence synthesis, controversies and proposed management strategies.

Authors:  Alexandru Burlacu; Simonetta Genovesi; Carlo Basile; Alberto Ortiz; Sandip Mitra; Dimitrios Kirmizis; Mehmet Kanbay; Andrew Davenport; Frank van der Sande; Adrian Covic
Journal:  J Nephrol       Date:  2020-05-29       Impact factor: 3.902

Review 2.  Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.

Authors:  Gates Colbert; Nishank Jain; James A de Lemos; S Susan Hedayati
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-17       Impact factor: 8.237

Review 3.  Applications of cardiac biomarkers in chronic kidney disease.

Authors:  Alexander Kula; Nisha Bansal
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-08-04       Impact factor: 3.416

4.  Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic Dialysis.

Authors:  Nishank Jain; Milind A Phadnis; Suzanne L Hunt; Junqiang Dai; Theresa I Shireman; Clayton L Davis; Jawahar L Mehta; Rafia S Rasu; S Susan Hedayati
Journal:  Kidney Int Rep       Date:  2021-07-03

5.  Optimal cut-off value of high-sensitivity troponin I in diagnosing myocardial infarction in patients with end-stage renal disease.

Authors:  Eunsoo Lim; Min-Jeong Lee
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

6.  Response to Zhou et al. regarding Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19).

Authors:  Alexander Tan; Daniel M Jones; Mahmood Ahmad
Journal:  Int J Cardiol       Date:  2021-02-22       Impact factor: 4.164

7.  Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease.

Authors:  Alexander J Kula; Ronit Katz; Leila R Zelnick; Elsayed Soliman; Alan Go; Michael Shlipak; Rajat Deo; Bonnie Ky; Ian DeBoer; Amanda Anderson; Rob Christenson; Stephen L Seliger; Chris Defilippi; Harold I Feldman; Myles Wolf; John Kusek; Tariq Shafi; Jiang He; Nisha Bansal
Journal:  Nephrol Dial Transplant       Date:  2021-12-02       Impact factor: 5.992
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.